#evergreening — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #evergreening, aggregated by home.social.
-
Am currently coming back from holiday to an #Evergreening project for a system with hundreds of clusters, thousands of #K8s hosts and tens of thousands of workloads, and wondering what new hellscapes the team will have uncovered in the last two weeks.
Once more into the breach! -
US Senators place blame for sky-high drug prices on abuse of the patent system
Democrats and Republicans accused drug-makers of taking advantage of patents to keep cheaper competition off the market.
#patent #access2meds #healthcare #drugs #uslaw #uspol #evergreening #competition
-
CW: Long thread/5
These companies get billions in research subsidies, invaluable government patent privileges, and near-total freedom to abuse the patent system with #evergreening:
https://pluralistic.net/2023/11/23/everorangeing/#taste-the-rainbow
The most amazing things about monopolies is how the contempt just *oozes* out of them. It's like these guys can't even *pretend* to give a shit. You want guillotines? Because that's how you get guillotines.
5/
-
CW: Long thread/20
In service to that end, pharma companies have perfected a process called #evergreening, where they dribble out ancillary patents after their initial filing, covering minor reformulations, delivery systems, or new uses.
Evergreening got a moment in the public eye earlier this year, with #JohnGreen's viral campaign to shame #JohnsonAndJohnson out of using evergreening to restrict poor countries' access to #TB medication:
https://armandalegshow.com/episode/john-green-part-1/
20/
-
CW: Long thread/2
There's plenty wrong with this argument. For one thing, pharma companies use their monopoly winnings to sell drugs, not invent drugs. For every dollar pharma spends on research, it spends three dollars on marketing:
And that "R&D" isn't what you're thinking of, either. Most R&D spending goes to "#evergreening" - coming up with minor variations on existing drugs in a bid to extend those patents for years or decades:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680578/
2/
-
Big Win Against #Evergreening For Tuberculosis Sufferers In India, But Will Johnson & Johnson Allow Those In Other Countries To Benefit? - https://www.techdirt.com/2023/04/05/big-win-against-evergreening-for-tuberculosis-sufferers-in-india-but-will-johnson-johnson-allow-those-in-other-countries-to-benefit/ #patents #tb
-
Thanks To #Evergreening And Legal Threats, AbbVie Has Earned $114 Billion Since 2016 From A Drug Whose Key Patent Expired Back Then - https://www.techdirt.com/2023/02/10/thanks-to-evergreening-and-legal-threats-abbvie-has-earned-114-billion-since-2016-from-a-drug-whose-key-patent-expired-back-then/#comments the patent system is not fit for purpose... #humira
-
Reading my new #JohnsHopkins colleague #RaviGupta's paper on new drug formulations in #JAMAHealthForum
https://pubmed.ncbi.nlm.nih.gov/35977259/
Levels of devious #pharma and clever data
Devious + #NewToMe: #Evergreening #ProductHopping
Super Cool #data: #DrugInnovativeness and #Prescrire